Clinical bottom line
Advanced imaging techniques, including diffusion-weighted imaging (DWI), contrast-enhanced ultrasound (CEUS), and dynamic contrast-enhanced MRI (DCE-MRI), improve differentiation between benign and malignant breast lesions beyond conventional mammography and ultrasound. DWI offers quantitative metrics such as apparent diffusion coefficient (ADC) values that reliably distinguish lesion types. CEUS provides spatiotemporal perfusion analysis enhancing lesion characterization. While MRI remains the most sensitive modality, combining these advanced techniques can optimize diagnostic accuracy and reduce unnecessary biopsies. However, variability in protocols and overlapping imaging features necessitate cautious interpretation within clinical context (Chen et al., 2024; He et al., 2021; Rahmat et al., 2022).
What the evidence shows
Chen et al. (2024) demonstrated that spatiotemporal analysis of CEUS significantly differentiates malignant from benign breast lesions by assessing vascular patterns and contrast kinetics, achieving high sensitivity and specificity in a prospective cohort.
He et al. (2021) reviewed the application of DWI, highlighting that malignant lesions typically exhibit lower ADC values due to higher cellularity. Their meta-analysis confirmed DWI’s utility as a noninvasive biomarker with pooled sensitivity and specificity exceeding 80%.
Rahmat et al. (2022) summarized current MRI trends, emphasizing DCE-MRI’s role in assessing lesion morphology and enhancement patterns. They noted that combining DCE-MRI with DWI improves diagnostic confidence and reduces false positives.
Stijven et al. (2009), although older, remain a landmark study validating DWI’s diagnostic value in breast imaging, supporting its integration into routine protocols.
REVIN et al. (2022) correlated clinical, histopathological, and imaging findings, underscoring the complementary role of advanced imaging in clinical decision-making.
Caveats and uncertainty
Advanced imaging techniques require standardized acquisition and interpretation protocols to ensure reproducibility.
Overlap in ADC values and enhancement patterns between some benign and malignant lesions can limit specificity.
CEUS availability and operator expertise vary across centers, potentially affecting generalizability.
MRI is resource-intensive and may not be feasible for all patients due to cost or contraindications.
Further large-scale prospective studies are needed to validate combined imaging algorithms.
How this may change practice
Incorporating DWI and CEUS alongside conventional imaging can refine lesion characterization, potentially reducing unnecessary biopsies and patient anxiety.
Radiologists should be trained in quantitative interpretation of ADC maps and CEUS perfusion metrics.
Multimodal imaging protocols integrating MRI, ultrasound, and advanced techniques may become standard in complex or indeterminate cases.
Improved imaging accuracy supports personalized management decisions, including surveillance versus intervention.
Health systems should consider resource allocation to expand access to advanced imaging modalities.